HOID provides targeted exposure to the humanoid robotics industry through equities, including common stocks and depositary receipts such as ADRs. The fund invests in US and non-US companies that derive at least 50% of revenue from, or commit at least 50% of assets to, humanoid robotics or enabling technologies. Eligible companies must have either commercialized a fully functional product or developed a functional prototypewhile progressing toward commercialization.The Adviser uses a proprietary selection process that evaluates thematic relevance, development stage, strategic importance, and competitive positioning. Portfolio weights are rebalanced at least quarterly. Some ADRs may involve Chinese variable interest entity (VIE) structures.